Disease Info Card

Primary Physiologic Amenorrhea

Information about Primary Physiologic Amenorrhea: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Primary Physiologic Amenorrhea

Most recent studies have shown that Primary Physiologic Amenorrhea shares some biological mechanisms with amenorrhea, congenital-abnormality, congenital-absence, congenital-adrenal-hyperplasia, cytogenetic-abnormality, disorders-of-sex-development, dwarfism, embryonic-mosaic, gonadal-dysgenesis, gonadoblastoma, hypogonadism, infertility, neoplasms, pituitary-diseases, polycystic-ovary-syndrome, premature-menopause, secondary-amenorrhea, sex-chromosome-aberrations, testicular-feminization, turner-syndrome.

Among the many pathways, these few ones have gauged particular interests from scientists studying Primary Physiologic Amenorrhea, and have been seen in publications frequently: Development Of Secondary Sexual Characteristics, Dna Replication, Excretion, Fertilization, Gonadotropin Secretion, Hormone Secretion, Interphase, Localization, Meiosis, Menarche, Menopause, Menstruation, Metaphase, Ovulation, Pathogenesis, Secretion, Sex Determination, Sex Differentiation, Spermatogenesis, Thelarche

Quite a number of genes have been found to play important roles in Primary Physiologic Amenorrhea, such as AKR1B1, AR, AREG, BRD2, CYP17A1, FDXR, FSHR, GGH, GH1, INS, LHCGR, NR5A1, PBX1, PLOD1, POMC, PRL, SRY, TRH. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.